Revised Team Page- DRAFT
Leadership
Therapeutics
Digital Health
Operations and Project Management
READDI was created to generate new broad-spectrum antiviral therapies to save lives in the current pandemic and to prevent emerging threats from becoming global catastrophes. To learn more, visit READDI’s website. CRISPR has supercharged the ability to conduct rapid and effective genetic and epigenetic screening. UNC’s facility is available on a fee-for-service basis to all UNC researchers. This will lead to rapid new discovery across a broad swath of research areas with a focus on accelerating drug discovery and development to find new genetic targets that may bring new future medicines. To learn more about the UNC CRISPR Screening Facility and its capabilities, visit their website. The SGC-UNC is a team of scientists dedicated to discovering and sharing selective, small molecule inhibitors of protein kinases. Their work aims to expand drug discovery across this important class of disease-relevant proteins and help speed the creation of new medicines for patients. For more information, visit their website.
UNC Antiviral Drug Discovery (AViDD) Center Project Management
Entrepreneur In Residence
Rapidly Emerging Antiviral Drug Development Initiative (READDI)
Scientific Cores
UNC CRISPR Screening Facility
Structural Genomics Consortium at the University of North Carolina at Chapel Hill (SGC-UNC)
